Scarica l'app Stockscreener
6.80
6.25%
0.40
Dopo l'orario di chiusura:
6.81
0.010
+0.15%
Ginkgo Bioworks Holdings Inc Borsa (DNA) Ultime notizie
How The Ginkgo Bioworks (DNA) Story Is Shifting As Analysts Revisit Growth And Risk - Yahoo Finance
Ginkgo Bioworks Posts On X "New in @sciam today: Researchers at Ginkgo and @OpenAI showed that an AI model working with an autonomous lab can design and iterate real biology experiments at unprecedented speed. From San Francisco, where GPT-5 - Benzinga
(DNA) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Ginkgo Bioworks (NYSE:DNA) Price Target Cut to $5.00 by Analysts at BTIG Research - MarketBeat
Ginkgo Bioworks price target lowered to $5 from $9 at BTIG - TipRanks
BTIG cuts Ginkgo Bioworks stock price target on autonomous lab shift - Investing.com
Ginkgo Bioworks Holdings Inc (DNA) PT Lowered to $5 at BTIG - StreetInsider
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Q4 2025 earnings call transcript - MSN
Risk Hedge: Why is Ginkgo Bioworks Holdings Inc stock going up2026 PreEarnings & Expert Approved Momentum Trade Ideas - baoquankhu1.vn
Macro Review: Can Ginkgo Bioworks Holdings Inc expand into new marketsInsider Buying & High Win Rate Trade Alerts - baoquankhu1.vn
Elon Musk Endorses 'Fundable' Jurassic Park: These De-Extinction Companies Are Already Making It Happen - Sahm
Ginkgo Bioworks (NYSE:DNA) Stock Rating Upgraded by Wall Street Zen - MarketBeat
Ginkgo Bioworks Bets on Autonomous Labs Amid Headwinds - The Globe and Mail
Weekly Recap: Is Ginkgo Bioworks Holdings Inc attractive for institutional investorsWall Street Watch & Momentum Based Trading Signals - baoquankhu1.vn
Ginkgo Bioworks Announces Date of Third Quarter 2024 Results Pre - GuruFocus
Ginkgo Bioworks Holdings, Inc. 2025 Q4ResultsEarnings Call Presentation (NYSE:DNA) 2026-03-03 - Seeking Alpha
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Q4 2025 Earnings Call Transcript - Insider Monkey
Ginkgo Bioworks Launches Ginkgo Cloud Lab, Powered by Autonomous Lab Infrastructure - AI Insider
Ginkgo Bioworks Launches Ginkgo Cloud Lab to Provide Remote Access for Researchers - marketscreener.com
Ginkgo Bioworks Makes Major Pivot (NYSE:DNA) - Seeking Alpha
Ginkgo Bioworks Launches Ginkgo Cloud Lab - marketscreener.com
DNA Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
A Look At Ginkgo Bioworks (DNA) Valuation As It Pivots To Robotics Labs And Biosecurity Divestiture - Sahm
DNA SEC FilingsGinkgo Bioworks Holdings Inc 10-K, 10-Q, 8-K Forms - Stock Titan
A Look At Ginkgo Bioworks (DNA) Valuation After Earnings Update And Invaio Collaboration - Yahoo Finance
DNABW Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Ginkgo Bioworks Divests Biosecurity Unit, Retains Minority Stake - The Globe and Mail
Ginkgo Bioworks Q4 Earnings Call Highlights - MarketBeat
Ginkgo Bioworks Reports Fourth Quarter and Full Year 2025 Financial Results, Announces Focus on Autonomous Labs Offerings and Divestiture of Its Non-Core Biosecurity Business - 富途牛牛
Analysts Offer Insights on Healthcare Companies: Ginkgo Bioworks Holdings (DNA) and Xenon (XENE) - The Globe and Mail
Ginkgo Bioworks Holdings Inc (DNA) Q4 2025 Earnings Call Highlights: Strategic Shifts and ... By GuruFocus - Investing.com Canada
Ginkgo Bioworks Q4 Loss Profile Reinforces Bearish Narratives On Cash Burn And Profit Timing - simplywall.st
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Ginkgo Bioworks Pivots To AI And Robotics After Rough Quarter - Benzinga
Ginkgo Bioworks Reports Fourth Quarter and Full Year 2025 Financial Results, Announces Focus on Autonomous Labs Offerings and Divestiture of its Non-Core Biosecurity Business - The Malaysian Reserve
Ginkgo Bioworks Holdings, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Ginkgo Bioworks to Sell Biosecurity Unit to Tower Biosecurity, Retaining 20% Equity Stake - TradingView
Ginkgo Bioworks (NYSE: DNA) trades Biosecurity arm for 20% Tower stake - Stock Titan
Ginkgo Bioworks to sell biosecurity unit for 20% stake in Tower Biosecurity - StreetInsider
Ginkgo Bioworks Q4 2025 Earnings Call Transcript - MarketBeat
Erste Asset Management GmbH Acquires 200,000 Shares of Ginkgo Bioworks Holdings, Inc. $DNA - MarketBeat
Ginkgo Bioworks (NYSE:DNA) Releases Quarterly Earnings Results, Beats Estimates By $0.38 EPS - MarketBeat
Ginkgo Bioworks reports fourth quarter and full year 2025 financial results - marketscreener.com
Ginkgo Bioworks Reports Fourth Quarter and Full Year 2025 Financ - GuruFocus
Ginkgo Bioworks Holdings Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Earnings call transcript: Ginkgo Bioworks Q4 2025 sees improved cash management - Investing.com
Ginkgo Bioworks Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Cost cuts narrow Ginkgo Bioworks (NYSE: DNA) 2025 net loss - Stock Titan
Press Release: Ginkgo Bioworks Reports Fourth Quarter and Full Year 2025 Financial Results, Announces Focus on Autonomous Labs Offerings and Divestiture of Its Non-Core Biosecurity Business - 富途牛牛
Ginkgo Bioworks 报告了截至 2025 年第四季度及全年的财务业绩，宣布将专注于自主实验室产品，并剥离其非核心的生物安全业务。 - 富途牛牛
Aug Outlook: Whats SILOs historical return2025 Pullback Review & AI Powered Buy/Sell Recommendations - baoquankhu1.vn
Insights into Ginkgo Bioworks Holdings's Upcoming Earnings - Benzinga
Ginkgo Bioworks Holdings Inc (DNA) Q4 2025: Everything You Need To Know Ahead Of Earnings - GuruFocus
Tech Rally: What are the future prospects of Ginkgo Bioworks Holdings Inc2025 Earnings Surprises & Weekly Watchlist for Consistent Profits - baoquankhu1.vn
What are Ginkgo Bioworks Holdings Inc.’s recent SEC filings showing2025 Support & Resistance & Safe Capital Allocation Plans - mfd.ru
Ginkgo Bioworks Holdings, Inc. (DNA): Investor Outlook on a Biotechnology Innovator with a 3.20% Potential Upside - DirectorsTalk Interviews
Ginkgo Bioworks Announces Date of Fourth Quarter and Full Year 2025 Results Presentation - 富途牛牛
Ginkgo Bioworks Holdings, Inc. (DNA) stock dips while market gains: Key facts - MSN
Why (DNA) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Ginkgo Bioworks and Invaio Sciences Enter Collaboration to Develop Manufacturing Technology for Peptide-based Agricultural Products - Investing News Network
Ginkgo Bioworks Signs Crop Protection Collaboration With Invaio - marketscreener.com
0.48%
1.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):